FIELD: medicine.
SUBSTANCE: group of inventions relates to the field of medicine and pharmaceuticals, namely to the use of a pharmaceutical composition consisting of a pharmaceutically effective amount of the amino acids glycine, arginine, cysteine and resveratrol to reduce high body fat, cholesterol, uric acid, blood glucose and accelerated aging in animals and humans, with the composition containing: 100-2500 mg of resveratrol, 3000-7000 mg of glycine, 300-5000 mg of arginine and 200-2500 mg of cysteine; and also to a method for reducing high content of body fat, cholesterol, uric acid and glucose in the blood in animals and humans, providing for the administration of the specified composition.
EFFECT: implementation of the group of inventions provides the effect of stimulating the proliferation of cell cultures and lymphocytes, reducing the formation of visceral fat induced by diabetes mellitus, managing glycemia with less or no insulin, cytoprotective effect, correcting the symptoms of metabolic syndrome and obesity.
11 cl, 2 tbl, 8 ex, 10 dwg
